Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Starting to see T-Trades on NXPL now. What scam has Fernandez begun running now?
Significant sell volume over there today, 33k shares dumped ... investors are finally seeing the light & have started to jump ship. IMO
The 2024 Shady CEO Award goes to Charles in Charge.
I have no idea, havent bought cigarettes in a few years. They do sell tall boys though 🥴
Walgreens still sells cigarettes in your state? About 4 years ago both CVS and Walgreens in NY can no longer sell tobacco products by law.
I think another factor is they're expensive. I'm not on medication, thank God, but any sort of OTC item or food item is expensive compared to a grocery store.
I personally don't shop there. Walgreens is good for cigarettes.
Locations will tell you why.
Lots of retail stores are leaving those locations as well.
Walgreens set to close numerous unprofitable locations
https://amp.cnn.com/cnn/2024/06/27/business/walgreens-closures
I’d be shocked if she agrees. She lives the life of luxury right now. Why subject herself to this job. The country is in turmoil and don’t believe our adversaries will have fear of her. But what do I know??
I have heard Michelle Obama being mentioned a lot as a replacement.
I expect nothing that will benefit us at this point…
So have you connected with Armen yet?
$20 would be around 10 cents pre split. I don’t think that’s outlandish to ask for at all.
I would say that's conservative and add maybe around 25% for the whole unit.
How I think company should be valued versus current valuation is obviously two different things.
A big problem is the only significant news announced from last two years was a reverse split. No conference calls. Barely any PRs. Market has forgotten about RXMD. You go silent on the OTC, price will reflect that.
Will things finally change after the merger? Hopefully so, but we’ll see
Speaking just for RXMD only. Not the soon to be combined entity.
Ok then why are we down here? The market sure isn’t agreeing with that sentiment.
Good morning
Is this just for Rxmd or the whole unit with nxpl ect?
You can cherry pick a number of ways to assess a company’s valuation. I like using a basic market cap of 1-2x annual revenues to serve as a baseline. At current O/S, that’d be a PPS of $10-$20.
$20 would be around 10 cents pre split. I don’t think that’s outlandish to ask for at all.
As Trackdude posted, a 9.5 million dollar market cap is an absolute joke for a company closing in on 60 million $s in revenue. The $26 million in cash sitting in the bank will eventually be put to work. A nice acquisition will do wonders.
I agree and the rest will be alot easier to watch.
While what you say is true at the moment, what do you expect to happen in the near future? I expect to see them gobble up another company.
$RXMD
How ya'll didn't see this coming is beyond me? The one year charts of both RXMD & NXPL look nearly identical because the same Mook is in charge of both companies.
The writing was on the wall, one only needed to see how he ran NXPL to determine what was going to become of RXMD. 🙊🙈🙉 See it now?
RXMD's organic growth took nearly a decade of hard work, perseverance and top-notch professionalism for Ms. Mars & Armen to achieve the $40m market cap before current CEO screwed shareholders.
It took "Fernandez the Flop" only 18 months to reduce that by 75%. Such a disgrace, this CEO needs to put his millionaire ego aside and tap out ASAP as the leader of this once thriving company.
TD you're in financials no? What's your "fair" market valuation based on numbers?
A $9.5 million market cap currently is an absolute joke for an OTC company on pace to make $60 milllion in revenues this year
lol, only people they are fleecing are the original investors in rxmd
three sets of matching (bid/ask) trades this morning.
Email Glickman and he forwards them to Fernandez
Light up his LinkedIn page with colorful comments, that will give his industry colleagues some real insight into his shady business practices. 👍👍
Water cooler chats around that office will soon be plotting for a mutiny, IMO.
Is there an email address that Charles monitors?
Hitler killed Jews while Schindler freed ‘em
And Foreman was the champ until Ali beat him
Mobutu was a killer and this well-known
Fernandez & Board keep acting like they’re Corleone. 😉
I do not think so. I think we will continue to get the silent treatment. Why? Because they are not done yet. They are in building mode and have a few more companies to fleece.
$RXMD
I don’t think remaining quiet for another 45 days will be difficult for these guys….
Holt from talking with Mr glickman, Fernandez is aware of the shareholders concerns and complains. He. Has gotten the message but his attorneys are muzzling him. I simply meant in my post that shareholders have to keep pressuring him by calling and emailing.
The concerning thing about this post is that you implied at the end that Fernandez hasn't gotten the message. He sees no problem with what he's done. He couldn't care less about RXMD shareholders which is ironic because he has shares.
If they purposely depressed the share price…yes.
It's both unethical and illegal. If we had proof, we'd easily win a class action lawsuit and recoup plenty of our investment. Fernandez was probably smart enough not to leave a paper trail, though.
It's obvious we've gotten absolutely fleeced by the board of directors and Fernandez.
Wouldn’t that be unethical if not illegal?
LOL!! Actually, I thought the same thing. Guess we'll find out soon enough. Bottom line is that the fundamentals are strong. If Fernandez manages the merger correctly, the share price should move a lot higher.
I did say If.
JS - You may be right, but why do it in the first place...makes for unhappy shareholders and keeps new investors away..
My thought is, if RXMD share price was being suppressed to lower the merger conversion price, then it will get unleashed once merger is complete by way of NXPL share valuation and showing profits.
Thanks for the reminder. In fact he did. Said it was done by an independent valuation company. I told him that it was crap and not a true valuation at all. He knows that shareholders are fed up with what's going on and I believe that if enough of us stay on his a$$ and call them out Fernandez will get the message.
My pleasure.
Thanks Gedi. Did he comment on the valuation of RXMD in the merger being heavily in favor of NXPL?
Thanks again gedi8
Followers
|
744
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
194975
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |